Therapeutic Potential of 1,8-Dihydroanthraquinone Derivatives for Breast Cancer

Breast cancer (BC) is the most common malignancy among women worldwide. In recent years, significant progress has been made in BC therapy. However, serious side effects resulting from the use of standard chemotherapeutic drugs, as well as the phenomenon of multidrug resistance (MDR), limit the effec...

Descripción completa

Detalles Bibliográficos
Autores principales: Okon, Estera, Gaweł-Bęben, Katarzyna, Jarzab, Agata, Koch, Wojciech, Kukula-Koch, Wirginia, Wawruszak, Anna
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648492/
https://www.ncbi.nlm.nih.gov/pubmed/37958772
http://dx.doi.org/10.3390/ijms242115789

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648492/
https://www.ncbi.nlm.nih.gov/pubmed/37958772
http://dx.doi.org/10.3390/ijms242115789

Ejemplares similares